Trials / Terminated
TerminatedNCT03972813
Optimizing HPV Vaccine Introduction in Shanghai, China
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,021 (actual)
- Sponsor
- University of Michigan · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Within low, middle, and upper income countries, low vaccine coverage results from both obstacles to vaccine access and low confidence in vaccine programs. Thus, it is critical to determine how best to enhance trust in vaccines as increasing numbers of vaccines are recommended for use. Even though the context accompanying the initial roll-out of a vaccine can have a large impact on people's perceptions of the vaccine and the corresponding disease, it is not clear how to best introduce a vaccine to increase public confidence and enhance uptake. The US roll-out of the human papillomavirus (HPV) vaccine framed HPV as a sexually transmitted infection, which proved to be an impediment to efforts to increase vaccine uptake \>10 years after its introduction. This study will use an educational experiment, where parents of children will be exposed to information about the HPV vaccination in different ways. Parents will be introduced to the HPV vaccine through different scenarios with varying emphases (i.e., age at vaccination, types of transmission, type of cancer prevention). The aim will be to determine how the framing of the HPV vaccination across several dimensions affects short-term willingness to receive it.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Broadened information about cancers | Caregivers receive information that HPV causes more than just cervical cancer. |
| BEHAVIORAL | Information about STDs | Caregivers learn that HPV is an STD. |
| BEHAVIORAL | Information about infectious disease | Caregivers learn that HPV is infectious (but information that it is an STD is omitted). |
| BEHAVIORAL | Recommendation for children 12 years old | Caregivers are prompted to get their child vaccinated when the child is 12 years old. |
| BEHAVIORAL | Recommendation for children 18 years old | Caregivers are prompted to get their child vaccinated when the child is 18 years old. |
| BEHAVIORAL | Standard age information | Caregivers are given information about when the HPV vaccination can be given in China, but no additional recommendations. |
| BEHAVIORAL | Cervical cancer | Caregivers are told that HPV causes cervical cancer. |
| BEHAVIORAL | Blank information about communicability | Caregivers are not given any information on how HPV is spread. |
Timeline
- Start date
- 2019-05-28
- Primary completion
- 2019-08-31
- Completion
- 2019-08-31
- First posted
- 2019-06-04
- Last updated
- 2025-01-15
- Results posted
- 2020-01-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03972813. Inclusion in this directory is not an endorsement.